Stockreport

LAVA Therapeutics Granted Full Waiver for RVO Payment Obligation [Yahoo! Finance]

LAVA Therapeutics N.V. - Ordinary Shares  (LVTX) 
PDF UTRECHT, The Netherlands and PHILADELPHIA, April 16, 2025 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (NASDAQ: LVTX, “LAVA,” “the Company”), a clinical-stage immuno-onco [Read more]